Drug Database
Back to search

United States· US:10122-610_e472cde4-d29e-44b2-b1ca-a6f4fcc01b1d

Cleviprex

A clevidipine product containing clevidipine, registered in United States by Chiesi USA, Inc.. The same ATC class is registered in 8 of our 19 countries.

ATC C08CA16US label

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedCleviprexATCC08CA16REGISTER NO.US:10122-610_e472cde4…PACKS LISTED2CHECKEDSeptember 27, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about clevidipineAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Clevidipine is registered in 8 of 19 countries.

Countries holding a registration under ATC C08CA16 (clevidipine), each read from that country’s own register.

  • This record: United States, from FDA National Drug Code directory (United States)
  • 4 of them publish a price we can compare per daily dose
Search clevidipine products by name

Clevidipine · ATC C08CA16

8 / 19 countries

  • Belgiumprice
  • Canada
  • Franceprice
  • Germany
  • Netherlands
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
CLEVIDIPINE
Manufacturer
Chiesi USA, Inc.
Country
United States (US)
ATC code
C08CA16
ATC class
Clevidipine
Defined daily dose
0.12 g, P
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
September 27, 2026

Packs & prices · 2

  • ndc11
    1012261010
    10 CARTON in 1 CARTON (10122-610-10) / 1 VIAL, SINGLE-USE in 1 CARTON (10122-610-01) / 50 mL in 1 VIAL, SINGLE-USE
  • ndc11
    10122-610-10

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

92 interactions on record for clevidipine.

Graded by severity as the source publishes them — 5 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check clevidipine against other medicinesHow interaction checks work

Clevidipine · interactions on record

92 records

  • 5 severe
  • 85 moderate
  • 1 minor

Most severe, free to view

  • DolasetronA04AA04severe
  • CeritinibL01ED02severe
  • CeritinibL01XE28severe
  • SiponimodL04AA42severe

1 more interaction with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Clevidipine in 9 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All clevidipine products

Authorised across Europe · EMA

The same active substance is authorised in 9 EEA countries. Names it is sold under:

  • Austria · Cleviprex
  • Belgium · Cleviprex
  • Germany · Cleviprex
  • Spain · Cleviprex
  • France · Cleviprex
  • Italy · Cleviprex
  • Luxembourg · Cleviprex
  • Netherlands · Cleviprex
  • Sweden · Cleviprex

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/8c4bf129-19f9-42d9-93e0-05429fe22e0f
GET /v1/drugs/8c4bf129-19f9-42d9-93e0-05429fe22e0f?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "route": "INTRAVENOUS",
  "source": "ndc",
  "strength": ".5",
  "substance": "CLEVIDIPINE",
  "productndc": "10122-610",
  "dosage_form": "EMULSION",
  "dea_schedule": null,
  "strength_unit": "mg/mL",
  "application_number": "NDA022156",
  "marketing_category": "NDA"
}
API referenceMCP serverPlans

See everything about clevidipine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console